Orange County Pulls Johnson & Johnson Vaccine Due to Blood Clotting Concerns

Orange County Pulls Johnson & Johnson Vaccine Due to Blood Clotting Concerns
A nurse draws from a vial of Johnson & Johnson COVID-19 vaccine, in Los Angeles on March 25, 2021. Lucy Nicholson/Reuters
|Updated:

The Orange County Health Care Agency (OCHCA) has suspended the use of the Johnson & Johnson COVID-19 vaccine at its point-of-distribution (POD) sites.

The pause in administering the one-dose vaccine, which was approved for emergency use by the FDA on Feb. 27, came under the guidance of the Centers for Disease Control and Prevention (CDC). The recommendation came “out of an abundance of caution” following six reports of severe blood clotting in vaccine recipients throughout the country.

Drew Van Voorhis
Drew Van Voorhis
Author
Drew Van Voorhis is a California-based daily news reporter for The Epoch Times. He has been a journalist for six years, during which time he has broken several viral national news stories and has been interviewed for his work on both radio and internet shows.
twitter
facebook
Related Topics